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OPEN
ORIGINAL ARTICLE
FBXW7 regulates DISC1 stability via the
ubiquitin-proteosome system
K Yalla1,8, C Elliott1,2,8, JP Day1, J Findlay1, S Barratt1, ZA Hughes3, L Wilson3, E Whiteley1, M Popiolek3, Y Li4, J Dunlop5, R Killick2,
DR Adams6, NJ Brandon5, MD Houslay7, B Hao4 and GS Baillie1
Disrupted in schizophrenia 1 (DISC1) is a multi-functional scaffolding protein that has been associated with neuropsychiatric
disease. The role of DISC1 is to assemble protein complexes that promote neural development and signaling, hence tight control of
the concentration of cellular DISC1 in neurons is vital to brain function. Using structural and biochemical techniques, we show for
we believe the ﬁrst time that not only is DISC1 turnover elicited by the ubiquitin proteasome system (UPS) but that it is orchestrated
by the F-Box protein, FBXW7. We present the structure of FBXW7 bound to the DISC1 phosphodegron motif and exploit this
information to prove that disruption of the FBXW7-DISC1 complex results in a stabilization of DISC1. This action can counteract
DISC1 deﬁciencies observed in neural progenitor cells derived from induced pluripotent stem cells from schizophrenia patients with
a DISC1 frameshift mutation. Thus manipulation of DISC1 levels via the UPS may provide a novel method to explore DISC1 function.
Molecular Psychiatry (2018) 23, 1278–1286; doi:10.1038/mp.2017.138; published online 20 July 2017
INTRODUCTION
Disrupted in Schizophrenia 1 (DISC1) is a susceptibility gene for a
range of psychiatric disorders and was identiﬁed in a Scottish
family with a high frequency of mental illness.1 The many
biological functions attributed to DISC1 include roles in neural
development, neuronal differentiation/migration and synapse
formation/maintenance (reviewed by Brandon and Sawa2). These
all appear to occur by the ability of DISC1 to interact with a diverse
set of signaling proteins located in distinct intracellular compart-
ments, providing what has been termed the ‘DISC1 interactome’.3
Insights into the molecular mechanisms modulated by DISC1
only began to emerge following elucidation of the biology of
DISC1-interacting proteins and protein complexes assembled by
DISC1.4 As certain neuronal signaling complexes depend on DISC1
to assemble them with correct stoichiometry, it is clear that DISC1
levels must be maintained at the appropriate concentration in
multiple cellular locations simultaneously. Little, however, is
known about the processes that regulate the synthesis and
degradation of DISC1.
Protein degradation by the proteosome and lysosome is a
dynamic process that is crucial for neurodevelopment, synaptic
plasticity and neuronal self-renewal.5 Indeed, the balance between
protein synthesis and degradation in neurons is now regarded as a
control point for regulation of processes that underpin learning
and memory.5 Recent evidence suggests that the half-life of
speciﬁc neuronal proteins can be profoundly inﬂuenced by
synaptic activity, where the stoichiometry of such proteins is
uniquely tailored in a manner that promotes memory formation.
Crucial to this process is the compartmentalization of protein
turnover at the synapse, which maintains optimal levels of the
evolutionarily conserved macromolecular signaling complexes
that are required for neural development and synaptic
transmission.6 Interestingly, DISC1 protein levels are decreased
in subjects carrying the t(1;11) DISC1 translocation,7 a DISC1
frameshift mutation8,9 and in the lymphocytes of a small cohort of
patients diagnosed with schizophrenia.10 DISC1 transcripts are
also decreased in patients with bipolar disorder.11 In contrast,
DISC1 levels appear unchanged in the hippocampus and
dorsolateral prefrontal cortex of postmortem human brain
samples extracted from patients with schizophrenia.12 In addition,
one study has demonstrated that DISC1 transcript levels actually
decrease in cells collected from schizophrenic patients treated for
acute psychosis, suggesting that antipsychotics might potentially
regulate the levels of DISC1 in the cell.13 These observations point
to a key role for DISC1 in the development of a normally
functioning brain. However, nothing is known about the molecular
mechanisms that ﬁne tune DISC1 levels in neurons.
Here, we demonstrate a novel mechanism for DISC1 turnover.
This occurs through the ubiquitin-proteosome system (UPS) and
involves a speciﬁc interaction between DISC1 and the E3 ubiquitin
ligase, FBXW7, an F-box protein component of the cullin-RING
ubiquitin E3 ligase superfamilies.14 The F-box proteins recruit
speciﬁc substrates to the RING E3 core through their variable
carboxy-terminal protein-interaction domains. Through comple-
mentary structural and biochemical approaches, we show that
DISC1 contains a ‘phosphodegron’ (PD) binding site for FBXW7
and that a cell-permeable peptide mimic of this sequence can
block UPS-mediated DISC1 degradation. Indeed, this peptide can
restore DISC1 levels to normal levels in neural progenitor cells
derived from induced pluripotent stem cells from schizophrenia/
major depression patients with a DISC1 frameshift mutation
(previously characterized by Wen et al.9).
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MATERIALS AND METHODS
HEK293 cell culture
HEK293 cells were sourced from ATCC (CRL-1573) and cultured as
described in the manufacturer’s protocol. DMEM (SIGMA) supplemented
with 10% fetal bovine serum, 2 mM L-glutamine, 100 U μg–1 penicillin-
streptomycin at 37 °C in a humidiﬁed atmosphere of 5% CO2. The cells
were passaged at about 80% conﬂuency. Cells were transfected with
plasmid DNA using polyfect transfection reagent (Qiagen) according to the
manufacturer’s instructions. HEK293 cells were treated with the
pharmacological agents cycloheximide (C7698) and MG132 (M7449)
(Sigma-Aldrich) or DISC1 disruptor peptides (custom synthesized by
Severn Biotech) as described in the text.
F-box siRNA library screen
ON Target PLUS siRNA libraries for F-box (G-105625-05) were purchased
from Dharmacon, Thermoﬁsher Scientiﬁc. HEK293 cells were plated at a
density of 3 × 103 cells per well in 6-well plates. Twenty-four hours after
incubation, the cells were transfected with control non-speciﬁc siRNA or
the test siRNA from the above library at a ﬁnal concentration of 25 nM per
each well using DharmaFECT (Dharmacon–Thermo Scientiﬁc) according to
the manufacturer’s protocol. The cells were incubated for 64 h at 37 °C in a
CO2 incubator. Gene expression knockdown was veriﬁed by western
blotting.
Generation of patient iPS cell-derived neuronal progenitors
All iPS derived neural progenitors were provided by Pﬁzer Neuroscience
(Cambridge, MA, USA). The iPS cell lines D2 and D3 and family control cell
line C1 were generated using a non-integrated approach by Dr Hongjun
Song at Johns Hopkins University and cultured as described previously.8
The Detroit iPS cell line was generated by Dr S. Engle at Pﬁzer
Neuroscience. Detroit 551 ﬁbroblasts were obtained from ATCC (CCL-110)
and maintained in Knockout DMEM (Life Technologies 10829-018), 15%
FBS (Life Technologies), 1x Non-essential amino acids (Life Technologies
11140-050), 2 mM L-glutamine (Life Technologies 25030-081), 1x Gentami-
cin (Life Technologies 15710-072), 0.1 mM β-mercaptoethanol (Sigma
M-7522). The cells were reprogrammed with individual lentiviruses
expressing c-MYC, KLF4, SOX2, OCT3/4, NANOG, and LIN28. One colony,
Detroit 551-3, with ES-like morphology, high expression of pluripotency
markers (for example, OCT3/4, TRA-1-60, TRA-1-81, SSEA4), a normal
karyotype, a normal karyotype and the ability to form all three germ layers
in a teratoma assay was used in all subsequent experiments. The cells were
maintained on mitomycin C (Sigma M0503)-treated mouse embryonic
ﬁbroblasts (MEF) and grown in hPSC media [DMEM/F12 (Life Technologies
11330-057), 20% knockout serum replacement (Life Technologies, 10828-
028), 2 mM L-glutamine (Life Technologies 25030-081), 1x Gentamicin (Life
Technologies 15710-072), 0.1 mM β-mercaptoethanol (Sigma M-7522),
FGF2 (Life Technologies PHG0263)]. Cells were enzymatically passaged
using 1 mg ml–1 Dispase (Life Technologies 17105-0410) to every 4–6 days
to fresh MEF feeder cells.
Neuronal progenitor differentiation from iPS cell lines was performed as
described previously.8 The resulting neuronal progenitors were seeded in
six-wells plates pre-coated with 20 μg ml–1 poly-L-ornithine hydrobromide
(Sigma P3655)/5 μg ml–1 natural mouse laminin (Life Technologies 23017-
015)) and maintained in NP media [50% Neurobasal Media (Life
Technologies 21103-0490), 50% DMEM/F12 (Life Technologies 10565-
018), 0.5 ×N2, 0.5 × B27 (Life Technologies 17504-044), 1 mM L-glutamine
(Life Technologies 25030-081), 1x Gentamicin (Life Technologies 15710-
072), 10 ng ml–1 EGF (R&D Systems 236-EG), 10 ng ml–1 FGF2 (Invitrogen
PHG0263)]. Cells were passaged by aspirating the media and washing
three times with PBS. One milliliter of Accutase (Invitrogen A1110501) was
used to gently detach the cells. Equal volume of DMEM-F12 media was
added to neutralize the enzyme activity and the cells were collected by
gently pipetting the suspension and centrifuged at 1000 r.p.m. for 5 min.
Supernatant was disposed and the cell pellet was resuspended in NP
media supplemented with 10 μM Rock inhibitor (Y-27632, Sigma) and
plated in 1:3 ratio on new pre-coated plates.
Immunoprecipitation and western blot
Brieﬂy, detergent-soluble proteins were isolated from cells by disruption in
lysis buffer 20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM Na2EDTA, 1 mM
EGTA, 1% triton, 2.5 mM sodium pyrophosphate, 1 mM β-glycerophosphate,
1 mM Na3VO4, 1 μg ml
–1 leupeptin, 10 mM DTT with Roche protease
inhibitor, phosSTOP (Roche, 04906837001). Detergent-insoluble proteins
were removed by centrifugation at 10 000 g for 10 min, and the soluble
fraction was retained. Cell lysates were adjusted to equal protein amount
(1 μg μl–1) using cell lysis buffer. Cell lysates normalized for the protein
concentration were incubated with mouse IgG (Millipore, 12487) Protein A
agarose beads for 2 h at 4 °C. Agarose beads were collected after a brief
centrifugation and supernatant is collected and added with tagged
agarose (Sigma, A2095) washed three times in cell lysis buffer and the ﬁnal
volume is adjusted to 750 μl and incubated overnight at 4 °C. The beads
were precipitated and washed three times to remove non-speciﬁcally
bound proteins. Immune complexes are eluted from the beads by boiling
them in SDS loading buffer (10% SDS, 300 mM Tris-HCl, pH 7.2, 0.05%
bromophenol blue, 50% glycerol, 10% β-mercaptoethanol). The complexes
were analyzed on SDS PAGE. Tagged agarose beads used in the present
study include: Flag (Sigma, A2220), HA (Sigma, A2095), V5 (Abcam,
ab1229).
Antibodies used in this study are detailed in Supplementary Table 1. As
there is some ambiguity concerning DISC1 isoforms and antibody
recognition of speciﬁc isoforms, we utilized a robustly characterized
antibody to the 100 Kilodalton (KD) form of DISC1 described in refs 15
and 16. Importantly, these studies showed a diminution of the immuno-
reactivity of the 100 KD form of DISC1 following genetic silencing of this
isoform. Western blotting was performed using the NuPAGE system
(Invitrogen) according to the manufacturer’s instructions. Brieﬂy cell lysates
were boiled in SDS loading buffer and loaded on to NuPAGE precast
4–12% gels in MOPS buffer along with pre-stained protein marker
(Bio-Rad) and resolved at 120 V. The resolved proteins were then
electrotransfered onto nitrocellulose membranes (Whatman) in 1X transfer
buffer with 20% methanol for 2 h at 25 V or overnight at 11 V. The
membrane was then blocked in 5% (w/v) non-fat dry milk (Marvel) in TBST
(25 mM Tris-HCl; pH 7.6, 100 mM NaCl, 0.5% Tween 20) for 1 h at room
temperature. Membranes were then probed with speciﬁc primary
antibodies at appropriate dilutions in 1% (w/v) marvel/TBST solution and
incubated for 2 h at room temperature or overnight at 4 °C. The
membranes were washed three times for 15 min each in TBST. Membranes
are then probed with the corresponding secondary antibody diluted in 1%
milk/TBST solution for 1 h at room temperature. Membranes were then
washed three times for 10 min. Chemiluminescence (ECL) western blotting
substrate (Thermo Scientiﬁc) was used for detecting the HRP conjugates
on the membrane. Chemiluminescent images of immune detected bands
were recorded on blue-light sensitive autoradiography X-ray ﬁlms, which
were then developed using the Kodak X-Omat Model 2000 processor and
band intensities were quantiﬁed using image J. Alternatively blots were
visualized using the Licor Odyssey system and quantiﬁed using LICOR
Image Studio Lite (Licor Biosciences).
Peptide array
Peptide libraries were produced by automatic SPOT synthesis and
synthesized on continuous cellulose membrane supports on Whatman
50 cellulose membranes using Fmoc-chemistry with the AutoSpot-Robot
ASS 222 (Intavis Bioanalytical Instruments, Köln, Germany) as previously
described.17 Phosphorylation of peptide array peptides by constitutively
active GSK3 (14-306, Millipore UK) was undertaken as previously
described.18 Phosphorylation was detected using a phospho-serine speciﬁc
antibody (ab9332, Abcam, UK).
Protein expression and puriﬁcation
Amino-terminal His6 tagged human FBXW7 (residues 263–707) and
truncated Skp1 (Schulman et al., 2000) were co-expressed as a dicistronic
message in Escherichia coli. The Skp1-FBXW7 complexes were puriﬁed by
Ni2+-nitrilotriacetic acid (NTA) afﬁnity chromatography followed by
tobacco eth virus (TEV) protease cleavage of the His6 tag, and by anion
exchange and gel ﬁltration chromatography. For crystallization, the Skp1-
FBXW7 complex was concentrated to 48 mg ml–1 by ultraﬁltration in
20 mM HEPES-Na (pH 7.4), 200 mM NaCl and 5 mM dithiothreitol (DTT). The
DISC1 peptides were synthesized chemically and puriﬁed by HPLC.
Crystallization and structure determination
The Skp1-FBXW7-DISC1 complexes were prepared by mixing a 48 mg ml–1
solution of Skp1-FBXW7 with a twofold molar excess of the DISC1 peptide
(residues 193–207, phosphorylated at Thr198 and Ser202) in 25 mM Tris-
HCl (pH 8.0), 200 mM NaCl, and 5 mM DTT. The Skp1-Fbw7-DISC1 peptide
complex was crystallized from 100 mM HEPES-Na (pH 7.4) and 1.2 M Li2SO4
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by the hanging-drop vapor diffusion method at 4 °C. Crystals were ﬂash-
frozen in solutions containing saturated Li2SO4. Diffraction data were
collected at the X29 beamline of the National Synchrotron Light Source
(NSLS). Data were processed using the HKL2000 suite. All crystals contain
one complex in the asymmetric unit. The structures were determined by
molecular replacement with the program MOLREP of the CCP4 suite19 and
the Skp1-FBXW7 structure19 was used as the search model. The DISC1
peptide was built using 2Fo—Fc and Fo—Fc maps with Coot20 and reﬁned
using REFMAC5.21 Residues 204–207 of DISC1 are not visible in the
electron density maps, and presumably disordered.
Isothermal titration calorimetry
All measurements were performed at 25 °C with a NANO ITC System (TA
Instruments, New Castle, DE, USA). Protein samples were dialyzed against a
solution containing 20 mM HEPES-Na (pH 7.4), 200 mM NaCl, and 2 mM
β-mercaptoethanol. Typically, the concentrations of Skp1-FBXW7 and
DISC1 peptides were 50 mM and 1 mM, respectively. Titration data were
analyzed using the TA Nano Analyze software, and the reported
dissociation constants and their standard deviations were derived from
two to three independent measurements.
Data collection and statistics
All experiments were replicated at least three times as described in the
ﬁgure legend. Statistical analyses used for comparison are reported in each
ﬁgure legend. Power calculations were undertaken to evaluate appropriate
samples sizes for each experimental procedure.
RESULTS
The Ubiquitin-Proteosome System regulates DISC1 turnover
Endogenous protein levels of DISC1 in HEK293 cells are rapidly
decreased following cycloheximide treatment (Figure 1a) and
elevated after application of the proteosome inhibitor MG132
(Figure 1b), suggesting that DISC1 turnover is regulated by the
UPS. Exogenously HA-tagged DISC1 protein expression is tran-
siently increased following MG132 treatment and HA-DISC1
immunoprecipitates co-purify with ubiquitin after a 30 min
exposure to MG132 (Figure 1c). Antibodies speciﬁc for K48-
linked chains recognized the ubiquitin associated with DISC1
immunoprecipitates, further supporting the notion that the UPS
regulates DISC1 stability (Figure 1d). Indeed, DISC1 ubiquitination
can be ampliﬁed by over-expression of either DISC1 or ubiquitin
in a manner that was not enhanced further by MG132
(Supplementary Figure 1a).
Mass spectrometry following excision of DISC1 protein bands
allowed us to identify the predominant ubiquitination site on
DISC1 as lysine 372 (K372) (Supplementary Figure 1b). However,
that ubiquitination was still evident in a K372R mutant, albeit
occurring at a signiﬁcantly lower level when compared with wild-
type (Supplementary Figure 2), suggests that there may be
additional ubiquitination site(s) on DISC1. Although it may be that
such site(s) are cryptic and only evident when ubiquitination is
ablated at the major lysine 372 site through mutation.
To identify the E3 ligase responsible for DISC1 ubiquitination we
utilized a siRNA library against all known human F-Box proteins
(see Materials and Methods). This allowed us to demonstrate that
silencing of FBXW7 speciﬁcally and robustly increased protein
levels of DISC1 in HEK293 cells (Figure 1e and Supplem-
entary Figure 3B). MYC, a well-characterized substrate for
FBXW7 exhibited a similar pattern of upregulation to DISC1
(Supplementary Figure 3B), adding another level of validation to
the notion that DISC1 is an FBXW7 substrate.
FBXW7 binds directly to DISC1 to regulate turnover
To verify FBXW7 as the F-Box ligase for DISC1, we transiently
overexpressed either wild-type FBXW7 or a mutant FBXW7 that
was devoid of the F-Box domain (meaning that it could not
interact with other members of the E3 ligase complex) and
evaluated endogenous levels of both DISC1 and MYC, a known
FBXW7 substrate (Figure 2a). Both DISC1 and MYC protein levels
were signiﬁcantly decreased following expression of active FBXW7
but not the mutant.
DISC1 half-life following cycloheximide treatment was also
shortened in cells expressing recombinant FBXW7 (Supplementary
Figure 3A). Furthermore, FBXW7 and DISC1 exist together in a
protein complex in cells, being co-immunoprecipitated from cells
co-expressing FLAG-FBXW7 with either GFP-DISC1 or V5-DISC1
(Figure 2b). Furthermore, immunoprecipitates of FLAG-DISC1 from
transfected cells contained endogenously expressed FBXW7
(Figure 2c).
As FBXW7 binds to PD motifs on substrates that contain the
consensus ‘TPPxS’ (Figure 2f),22 we undertook sequence analysis
of the DISC1 sequence and identiﬁed a candidate PD motif,
Figure 1. DISC1 turnover is regulated by the ubiquitin-proteosome
system. (a) HEK293 cells were treated with cycloheximide (50 μg ml–1)
for indicated times before cellular lysates were isolated and probed
for DISC1 and another known FBXW7-substrate Myc. Levels of DISC1
protein were evaluated by densitometry (bar-chart, n= 3 ) (b) HEK293
cells were treated with indicated concentrations of MG132 (10–60 μM)
for 1 h before cellular lysates were isolated and probed for DISC1. (c)
HEK293 cells were transfected with HA-DISC1 and treated with
MG132 (10 μM) for indicated times before cellular lysates were
prepared (upper panels) and blotted for HA and Tubulin. HA-DISC1
levels were evaluated using densitometry (bar-chart, n=3). ‘Nt’
indicates no treatment control. The HA-tag was immunoprecipitated
and blotted for HA and ubiquitin (lower panels). (d) HEK293 cells were
transfected with HA-DISC1 and treated with MG132 (10 μM) for 1 h
before cellular lysates were prepared and HA-tag immunoprecipi-
tated and blotted for HA (lower panel) and ubiquitin chains linked
speciﬁcally via lysine 48 (upper panel). (e) A siRNA library against
human F-Box proteins was transfected individually into HEK293 cells,
before cellular lysates were recovered and blotted for endogenous
DISC1 and GAPDH. DISC1 levels were evaluated by densitometry
(bar-chart, n= 1).
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198TPPGS202. Using peptide array technology, a technique that
allows interrogation of a library of immobilized peptides,23 we
conﬁrmed the phosphorylation-driven interaction between pep-
tides containing the DISC1 PD motif and a puriﬁed protein
complex of Skp1-FBXW7 (Figure 2d). Inclusion of phosphorylated
versions of the residues 198T and S202 within the PD domain
dramatically increased the association of the FBXW7 complex
when compared with mono-phosphorylated or unphosphorylated
peptides (Figure 2d). Truncation analysis allowed us to delineate
the minimum core binding sequence within the PD domain as
197PTPPGSH203 (Figure 2e) and this peptide was used as a starting
point to develop a protein-protein interaction disruptor peptide
for the DISC1-FBXW7 complex. Rational rounds of peptide
substitution at non-essential positions 1, 4 and 7, in order to
increase afﬁnity, and at positions 2 and 6, to avoid the need for
labile phospho-groups within the PTPPGSH sequence, allowed us
to identify 11 peptides that exhibited more than a twofold
increase in binding potential for the FBXW7 complex, compared to
the dually-phosphorylated control sequence (Figure 3). All 11 had
N-methyl glutamic acid at position 6. Four of the identiﬁed
peptides (I11, I14, J3 and K13) were modiﬁed by addition of a
stearate group at the N-terminus to allow peptides to cross the
plasma membrane (a technique used successfully previously by us
and others24–27) to test their ability to affect the cellular protein
expression of endogenous DISC1 in HEK293 cells (Figure 4).
Peptides I11 and I14 (but not the unstearoylated versions of I11
and I14) robustly and signiﬁcantly increased DISC1 protein levels
whereas peptides J3, K13 and a control peptide, where the acidic
residues had been replaced with basic ones, did not (Figure 4a).
The predominant DISC1 band detected was the 100 KD species
(Supplementary Figure 10). The reasons behind the success of
stearoylated peptides I11 and I14 in upregulating DISC1 compared
with the failure of stearoylated versions of J3 and K13 remain
unclear as all four peptides showed similar binding on peptide
array. It is possible, however, that the N-methylation at position 2
confers resistance to peptidases. DISC1 upregulation was success-
ful at doses over 50μM (Figure 4b) but were relatively short lived
due to peptide instability (Supplementary Figure 4A). Improve-
ments to the stability, potency and cell permeability of the
peptide may be achieved by stabilizing alpha helices using novel
peptide stapling technology.28,29Interestingly, the protein levels of
other previously identiﬁed FBXW7 substrates (Notch1, c-Myc,
c-Jun and cyclin E)22 were not affected by treatment with peptides
Figure 2. FBXW7 binds DISC1 via a PD motif to regulate turnover of
DISC1. (a) HEK293 cells were transfected with FLAG-tagged FBXW7
or FLAG-tagged FBXW7 without the F-Box substrate-binding
domain (Δ-F). Lysates were prepared and blotted for DISC1,
c-MYC, FLAG and GAPDH. Relative levels of DISC1 expression were
calculated (right hand panel). *= Po0.05 as measured by Student’s
t-test, n= 3 (b) HEK293 cells were transfected with FLAG-FBXW7 and
GFP-DISC1 (upper panels) or FLAG-FBXW7 and V5-DISC1 (lower
panels). FLAG was immunoprecipitated from cell lysates and blotted
for FLAG, GFP and V5. (c) HEK293 cells were transfected with FLAG-
DISC1. FLAG was immunoprecipitated from cell lysates and blotted
for FLAG and endogenous FBXW7. (d) and (e) Peptide arrays of
sequences containing the DISC1 PD were overlayed with a puriﬁed
protein complex containing 6His-FBXW7 and Skp1. Arrays were then
probed for His tag. (f) Sequences of known FBXW7 substrates
contain a PD that is also present in DISC1.
Figure 3. Substitution analysis pinpoints novel binding motifs for
FBXW7. (a) Peptide array grids containing substitution of residues
within the core binding motif domain 197PTPPGSH202 (with a range
of native and non-native residues) were overlaid with a puriﬁed
protein complex containing 6His-FBXW7 and Skp1. mD and mE are
N-methyl aspartic acid and N-methyl glutamic acids respectively. (d)
and (e) are the D-forms of aspartic acid and glutamic acid. (b) Arrays
were then probed for 6His and spots that were over 200% of the
control identiﬁed by densitometry.
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I11 or I14 (Supplementary Figure 4B), suggesting that the
disruptor peptides were selective for the DISC1-FBXW7 interaction
(see Discussion section).
Phosphorylation of DISC1 at Thr198 and Ser202 is required for
FBXW7 binding.
To test whether phosphorylation of both the Thr198 and Ser202
sites in DISC1 is required for binding to FBXW7, we used
isothermal titration calorimetry (ITC) to measure the binding
afﬁnity of various phosphorylated DISC1 peptides to the Skp1-
FBXW7 complex (Supplementary Figure 5). The 7- and 15-residue
core peptides of DISC1 phosphorylated at Thr198 and Ser202
(denoted DISC1197–203/pT198/pS202 and DISC1193–207/pT198/pS202) bind
to Skp1-FBXW7 with dissociation constants (KD) of 17 ± 2 μM and
1.0 ± 0.2 μM, respectively (Figure 5a). By contrast, neither of the
singly phosphorylated DISC1193–207/pT198 and DISC1193–207/pS202
peptides gave a measurable enthalpy signal (Figure 5a). Thus,
speciﬁc interaction of DISC1 with the Skp1-FBXW7 complex
requires simultaneous phosphorylation at Thr198 and Ser202
within the DISC1 PD motif.
Identiﬁcation of GSK3 as a putative kinase for the DISC1
phosphodegron
To identify putative kinases responsible for phosphorylation of
residues T198 and S202 within the DISC1 phosphodegron were
used an in silico method using a group based prediction system
(iGPS, Cuckoo workgroup, v1.0).30 This algorithm uses known
consensus motifs to assign putative kinases for residues within a
sequence of interest, combined with protein-protein interaction
data as a major contextual factor to identify potential
false-positives. This analysis identiﬁed glycogen synthase
kinase-3 (GSK3) as the putative kinase responsible for DISC1
phosphorylation at both T198 and S202 (Supplementary Table 2),
this is in agreement with other FBXW7 substrates where the
central phospho-threonine is followed by a phospho-serine in the
+4 position, which acts to prime GSK3. In agreement with this
notion, active GSK3 was able to phosphorylate peptide arrays
containing the DISC1 motif 198TPPGS202 (Supplementary Figure
10E). DISC1 has been previously shown to directly bind to GSK3
and regulate its function,31,32 however this action may be
bi-directional as GSK3 may regulate DISC1 turnover by phosphor-
ylation of its phosphodegron.
Crystal structure of the tertiary Skp1-FBXW7-DISC1
phosphodegron complex.
To investigate the basis for phosphorylation-dependent binding of
FBXW7 to the DISC1 PD motif, the X-ray crystal structure of the
Skp1-FBXW7 complex bound to DISC1193–207/pT198/pS202 was
determined at 2.6 Å resolution (Supplementary Figure 6, depos-
ited structure 5V4B). As anticipated, residues 193–202 of the DISC1
peptide bind to the narrow face of the FBXW7 WD40 domain
extending from blades 6/7 at one side of the surface, across the
central channel, to blades 2/3 at the other side (Figures 5b and c).
The spatial arrangement of the DISC1 PD motif on the WD40 β-
propeller closely resembles that in other Skp1-FBXW-substrate
protein complexes33,34 (Supplementary Figure 8). The central ﬁve-
residue segment (Pro196, Pro197, pThr198, Pro199 and Pro200) of
DISC1 adopts a twisted U-shaped-backbone conformation to
enable dipping of the pThr198 phosphate group into the β-
propeller channel. Interestingly, residues 195–197 and 199–201
immediately preceding and following pThr198 form two left-
handed polyproline type II helices. As a result, the peptide chain
does not enter the beta-propeller channel and stays on top of the
blades, thereby facilitating pThr198 recognition by FBXW7. More-
over, the C-terminal pSer202 side chain binds outside the central
channel on top of blades two and three and also plays a critical
role in specifying and stabilizing the DISC1 PD motif required for
FBXW7 binding (see below).
DISC1-FBXW7 binding is mediated by both hydrogen bond
networks and van der Waals contacts (Figure 5d and
Supplementary Figure 7). The pThr198 phosphate group tucks
into a positively charged pocket at the inner rim of the FBXW7
β-propeller channel and makes charge-stabilized hydrogen bonds
with the guanidinium groups of Arg465, Arg479 and Arg505, as
well as the hydroxyl group of Tyr519 from blades three
and four (Supplementary Figure 7). The side chain of pSer202 is
oriented so as to allow its phosphate group to make hydrogen
bonds with the hydroxyl group of Ser462, the backbone amide of
Thr363 and the guanidinium groups of Arg441 and Arg479 on top
of blades two and three (Figure 5d and Supplementary Figure 7).
The three residues between pThr198 and pSer202 contribute
additional contacts to FBXW7 (Figure 5d and Supplementary
Figure 7). The pyrrolidine ring of Pro199 ﬁts into a sandwich-like
structure formed by the side chains of Trp425 and Arg479, while
the backbone carbonyl groups of Pro199 and Pro200 hydrogen
bond with the Arg479 side chain. Moreover, the DISC1 peptide
preceding pThr198 packs into two partially solvent-exposed
hydrophobic pockets on FBXW7. Pro196 and Pro197 engage in
van der Waals interactions with Val383, Val671 and Trp673 of
WD40 repeats 1 and 8, whereas Pro193, Glu194 and Val195
interact with Leu559, Leu583, Ala599 and Ala626 of WD40 repeats
5, 6 and 7. Thus, DISC1 recognition speciﬁcity is achieved by a
combination of satisfaction of hydrogen bond donors and
acceptors from pThr198 and pSer202 and a set of polar
residues ﬂanking the narrow face of the WD40 domain, together
Figure 4. Disruption of the FBXW7/DISC1 complex using cell-
permeable peptide analogs of the DISC1 PD upregulate DISC1
protein levels in HEK293 cells. (a) HEK293 cells were treated with the
indicated peptides (sequences delineated below Figure 4a) for 3 h
(100 μM) before cellular lysates were prepared and blotted for DISC1.
‘Str’ represents stearoylated peptides and ‘Us’ represents unstear-
oylated peptides. (b) HEK293 cells were treated with the indicated
concentrations of peptides I11 and I14 for 3 h before cellular lysates
were prepared and blotted for DISC1.
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with stacking interactions and van der Waals contacts. The
ternary Skp1-FBXW7-DISC1193–207/pT198/pS202 structure explains
why the doubly phosphorylated pThr198/pSer202 DISC1
motif is an optimal, high-afﬁnity degron (Figure 5a). These
structural and energetic features justify exploiting speciﬁc
DISC1-target site interactions at an atomic level to enable rational
improvement of potential DISC1 ubiquitination and degradation
inhibitors.
Disruption of the FBXW7-DISC1 complex restores DISC1 protein
levels in a human cellular model of psychiatric disease
DISC1 protein levels are known to be reduced in lymphoblastoid
cells from subjects carrying the t(1;11) DISC1 translocation35 and
iPS derived neurons from a DISC1 frameshift mutation,9 although
in the latter case, the causality of this mutation remains unclear
based on pedigree size and identiﬁcation of the mutation in
control subjects.36 We utilized human neuroprogenitor cells (NP
cells), differentiated from patient derived induced pluripotent
stem cells (iPS cells) from the latter genotype8,37 to determine
whether disruption of the FBXW7-DISC1 complex could restore
DISC1 protein expression to control levels. These cells have
previously been characterized by Wen et al.9 and exhibit a single
DISC1 band at 100 Kilodaltons.
In agreement with previous work,9 the 100 KD form of DISC1
protein (Supplementary Figure 10) levels in cells derived from
control subjects were signiﬁcantly higher than in cells derived
from subjects carrying the DISC1 frameshift mutation (Figure 6a).
We could detect the complex between DISC1 and FBXW7
endogenously in human iPS derived neural progenitors
(Supplementary Figure 10C) and the comparatively low levels of
DISC1 in patient-derived cells could be enhanced by MG132
treatment suggesting involvement of the UPS (Supplementary
Figure 10D). Crucially, we demonstrate that incubation of WT
DISC1 NP cells with stearoylated peptides I11 and I14 resulted in a
marked increase in endogenous DISC1 levels, suggesting that
DISC1 can be regulated via the action of FBXW7 in these cells
(Figure 6b). Pleasingly, application of the I11 and I14 peptides to
the frameshift DISC1 patient-derived cells also signiﬁcantly
increased DISC1 protein levels (Figures 6c and d). Moreover,
further analysis revealed that peptides I11 and I14 (but not control
peptide) enhanced levels of DISC1 in NP cells derived from
psychiatric disease patients to that of control subjects (Figure 6e).
Figure 5. Structure and interaction of the Skp1-FBXW7-DISC1 PD complex. (a) Dissociation constants determined by ITC for different DISC1 PD
peptides. (b) Overall architecture of the complex. Skp1, FBXW7, and DISC1 are in blue, green, and orange, respectively. (c) Binding of the
DISC1 peptide at the top face of the WD40 domain of FBXW7. The eight FBXW7 blades and the strands for one blade are labeled. (d) Close-up
view of the DISC1-FBXW7 interface showing interacting amino acids of FBXW7 (light green) and DISC1 (orange).
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DISCUSSION
DISC1 is a vital intracellular scaffold protein that orchestrates
neural cell differentiation and signaling,38 hence the ﬁne control
of DISC1 stability/turnover is fundamental for the maintenance of
brain function. In our efforts to investigate the factors regulating
DISC1 stability, we discovered that DISC1 turnover is regulated by
the UPS, but more speciﬁcally that FBXW7, the substrate recruiting
subunit of the Cullin-RING E3 ligase, orchestrates ubiquitination to
control protein levels of DISC1.
The half-life of DISC1 has been previously calculated at around
6 h and this can be increased following blockade of the UPS,39
suggesting that DISC1 can be modiﬁed by ubiquitin prior to its
proteolysis by the 26S proteosome. Indeed, we conﬁrm that DISC1
can be ubiquitinated on lysine 372 and that the ubiquitin chains
are linked at K48 (Figure 1), a requirement for high-afﬁnity binding
of the proteolytic substrate to the regulatory particle of the 26S
proteosome.40 To explore the molecular mechanisms underlying
DISC1 ubiquitination, we utilized a siRNA screen (Figure 1) to
identify FBXW7, an F-box protein subunit of an (Skp, Cullin, F-box)
SCF-type cullin-RING ubiquitin ligase complex,41 that functions as
a binding protein for DISC1. Other previously discovered
substrates of FBXW7 include proto-oncogene protein products
such as cyclin E, c-Myc and c-Jun,22 that mediate forward
momentum through the cell cycle. Interestingly, they also include
Notch, a protein that is a key regulator of neuronal differentiation,
migration and synaptic plasticity.42 All of these FBXW7 substrates
contain a characteristic TPPxS motif in which conserved Thr and
Ser residues are phosphorylated for their recognition by the SCF
complex.22,34 We demonstrate that double phosphorylation of the
DISC1 degron is essential to provide sufﬁcient afﬁnity for FBXW7
binding. Our crystallographic analysis reveals that the phosphate
groups of the DISC1 pThr198 and pSer202 residues interact with
two phosphate-binding sites on the WD40 domain of FBXW7 in a
manner analogous to those of cyclin E34 (Supplementary Figure 8).
The cyclin E degron forms a polyproline helix so as to enable
binding of two phosphate groups to the FBXW7 pockets, whereas
DISC1 utilizes two polyproline helical segments to promote
interaction with FBXW7. Moreover, hydrophobic interactions also
contribute to the stable association of the FBXW7-substrate
complexes. Our ITC data have shown that removing the four
mostly hydrophobic residues (Pro193, Glu194, Val195 and Pro196),
preceding pThr198, lowers the binding afﬁnity of DISC1 to
FBWX7 by 17-fold; these four residues form a more extended
conformation across the top of blades 5, 6 and 7, while the
corresponding residues in cyclin E adopt a β turn conformation.
Our structural studies provide a solid basis for future structure-
based drug discovery efforts to develop ligands that inhibit DISC1
degradation.
Studies with peptides derived from protein-protein interaction
interfaces can usefully allow both deﬁnition of the key con-
tributory binding determinants to such interactions as well as
deconvolution of the speciﬁc interactions that orchestrate deﬁned
downstream signaling events. Indeed, we have used this
technique extensively in the past to characterize novel functions
for proteins such as ARHGAP21,27 PDE8A25 and PDE4D,24,26
amongst others. Using modiﬁed versions of the minimum core
sequence of the DISC1 PD motif conjugated to a membrane-
permeabilising stearoyl group, we were able to upregulate DISC1
expression in a human cell line that expressed low levels of DISC1
protein (Figure 4). We were also able to rescue the depleted DISC1
protein levels observed in the same iPS cell-derived neural
progenitors from patients with a frameshift mutation of DISC1
that is known to lead to pre-synaptic deﬁcits (Figure 6).9
Importantly, our peptide restored DISC1 in patient cells back to
control levels (Figure 6e) and not to a super-elevated DISC1
protein concentration, which may lead to DISC1 aggregation with
associated physiological consequences to mitochondrial
trafﬁcking,43by disruption of binding to nuclear distribution
element 1 (NDEL1)44 or the dopamine transporter45 It has been
suggested that the mutant DISC1 protein produced by the
frameshift (mDISC1) interacts with wild-type DISC1 (wDISC1) to
form aggregates that both deplete the soluble pool of wDISC1
Figure 6. DISC1-FBXW7 disruptor peptides restore DISC1 protein
expression in neural progenitors derived from patient iPS cells
carrying a DISC1 mutation. (a) Relative DISC1 levels were deter-
mined in cellular lysates from neural progenitors derived from
different iPS cell lines as described previously.8 (b) Neural
progenitors derived from control subjects were treated with the
indicated peptides (100 μM) for 3 h prior to cellular lysate being
isolated and blotted for DISC1 and GAPDH. Relative DISC1 levels
were calculated by densitometry (n= 3). (c and d) Neural progeni-
tors derived from patients carrying a 4-bp deletion in the DISC1 gene
were treated with the indicated peptides (100 μM) for 3 h prior to
cellular lysate being isolated and blotted for DISC1 and GAPDH.
Relative DISC1 levels were calculated by densitometry (n= 3). (e)
Neural progenitors derived from control subjects and patients
carrying a 4-bp deletion in the DISC1 gene were treated with the
indicated peptides (100 μM) for 3 h prior to cellular lysate being
isolated and blotted for DISC1 and GAPDH. Relative DISC1 levels
were calculated by densitometry (n= 3).
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and promote its ubiquitination.9 This mechanism has been
proposed as an alternative to haploinsufﬁciency to explain why
so little DISC1 protein is expressed in these cells, however little
insight has been offered into the molecular events that underpin
this hypothesis. We conﬁrm that DISC1 can be ubiquitinated and
that FBXW7 is the likely E3 ligase that facilitates this modiﬁcation.
Our ﬁndings raise the possibility that disruption of FBXW7-
DISC1 complex could be considered as a novel therapeutic
strategy to combat reduced DISC1 levels that stem from
mutations resulting in DISC1 haploinsufﬁciency.1,7 However, the
relevance of DISC1 in sporadic chronic mental disease has yet to
be fully elucidated. A recent small study demonstrated that
diminished peripheral DISC1 protein levels are a disease trait
marker associated with sporadic schizophrenia and, interestingly,
with smokers even in the absence of psychosis,10 suggesting that
future opportunities may exist for an agent that selectively
increases endogenous DISC1 protein levels. Global inhibition of
FBXW7 would undoubtedly be deleterious as a number of cancers
arise following loss of FBXW7 function via hemizygous or
homozygous mutations in the FBXW7 gene.46 Recently, however,
the role of FBXW7 as a universal tumor suppressor was challenged
by the discovery that FBXW7 is essential for B-cell survival, acting
as a pro-survival factor in multiple myeloma via its regulation of
NF-κB protein levels.47 The ability of our peptide disruptors to act
speciﬁcally against the FBXW7-DISC1 interaction but not the entire
FBXW7-interactome highlights the importance of the unique
substrate side chain and backbone conformations in FBXW7
recognition. The selectivity could be a function of the relative
afﬁnities for the intact protein partners of FBXW7, as cyclin E
exhibits signiﬁcantly higher afﬁnity than DISC1, meaning that the
afﬁnity and intracellular concentration achieved with the cell-
permeable peptides conspire only to perturb the binding of
DISC1. Another explanation may center on the oligomerisation
status of FBXW7. It is known that that cyclin E exhibits two PD sites
—a higher afﬁnity, dually-phosphorylated C-terminal site and a
lower afﬁnity, singly phosphorylated N-terminal site.19 A dimeric
SCF model has been suggested that relies on the presence of both
PD sites, which cooperate to promote the binding and ubiquitina-
tion of cyclin E.19 It is possible that the sequence of DISC1 is such
that it cannot bind to a dimeric SCF assembly but requires a
monomeric SCF for ubiquitination. It is also noteworthy that two
FBXW7 arginines (R479 and R441) that ﬂank the phospho-Ser
binding site are only loosely engaged with the pSer on DISC1. The
distances are 4.3 and 4.9 Å between the phosphate and relevant
atoms on R479/R441, meaning that the pSer engagement is
altogether looser than the pThr engagement. It could be that a
dimeric SCF assembly might cause some tightening of the R479/
R441 clamp on the pSer. If that were the case, then it might
contribute to differential afﬁnities between DISC1 and other
FBXW7 partner proteins (with otherwise similar PDs), and that in
turn might provide a rationalization for the selectivity of the
DISC1-derived peptides (based on relative afﬁnities).
The general binding mode exhibited by the DISC1 peptide in
complex with FBXW7, where the peptide binds across the ‘BC-loop
face’ of the propeller (deﬁned in48), is well precedented amongst
β-propeller proteins. For example, the 7-bladed β-propeller, WDR5,
hosts a number of proteins in such a manner, including histone
H3,49 SET family lysine methyltransferases such as Mixed Lineage
Leukemia Protein-1 (MLL1)50 and components of the non-speciﬁc
lethal complex.51 In each of these cases the substrate protein
binds with a short linear peptide sequence of some 6–10 residues
dipping into the β-propeller canal funnel to provide focal
engagement. The propeller face on either side of the canal funnel
is sufﬁciently accommodating to allow a range of partner proteins
to bind, thereby establishing multiplicity within the WDR5
interactome. FBXW7 appears to be similarly adapted, albeit with
an expanded propeller structure (8 blades) and a different set of
focal molecular interactions and partner proteins.52
DISC1 represents a key molecular hub underpinning a number
of fundamental cellular functions and although peptides do not
readily pass the blood-brain barrier, our cell-permeable peptides
provide powerful tools to further elucidate the DISC1 biology
underpinning neurodevelopment and psychosis and may open
new routes to provide substrate-speciﬁc FBXW7 inhibitors for
therapeutic use.
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